MetaVia Inc. share price logo

MetaVia Inc. Share Price

NASDAQ: MTVA

Small Cap

$1.51

+0.01

(+0.67%)

as on

MetaVia Inc. Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.46
    $1.56
    downward going graph

    3.31%

    Downside

    3.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.17
    $23.10
    downward going graph

    22.52%

    Downside

    1429.80%

    Upside

    downward going graph

MetaVia Inc. share price movements today

Previous Close
$1.50
Open
$1.54
Volume
553.4K
Day's Low - High
$1.46 - $1.56
52 Week Low - High
$1.17 - $23.10

MetaVia Inc. Historical Returns

1 Month Return
-7.45 %
3 Month Return
-54.85 %
1 Year Return
-83.28 %
3 Year Return
0 %
5 Year Return
0 %

MetaVia Inc. Stock Fundamentals & Key Indicators

Check MetaVia Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.6M

EPS (TTM)

-2.44

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-195.61%

MetaVia Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MetaVia Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$7.6MNANA0.00%
BUY$45.0B144.14%145.058.45%
BUY$113.0B100.94%28.9832.94%
NA$35.6BNA123.515.37%
BUY$78.9B52.74%17.9931.41%

Stock Returns calculator for MetaVia Inc. Stock including INR - Dollar returns

The MetaVia Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

MetaVia Inc. investment value today

Current value as on today

₹18,332

Returns

-₹81,668

(-81.67%)

Returns from MetaVia Inc. Stock

-₹83,053 (-83.05%)

Dollar Impact

₹1,385 (+1.39%)

MetaVia Inc. Stock’s Investor Sentiment and Interest

Search interest for MetaVia Inc. Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-71% versus previous 30 day period

MetaVia Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-3
-5
-6
-10
-6
-5
-3
-4
-3
-2
EBITDA
-3
-2
-6
-10
-6
-5
-3
-3
-3
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-5
-6
-10
-5
-5
-3
-3
-3
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-5
-6
-10
-5
-5
-3
-3
-3
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MetaVia Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
Operating Income
-29
-15
-19
-15
-28
-13
EBITDA
-29
-15
-11
-15
-28
-13
Interest Expense
-
-
2
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-29
-15
-13
-12
-27
-12
Income Tax Expense
-
-
-
-
-
-
Net Income
-29
-15
-13
-12
-27
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

MetaVia Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-5
-6
-10
-5
-5
-3
-3
-3
-1
Operating Cash Flow
-3
-6
-7
-5
-5
-4
-3
-2
-4
Investing Cash Flow
0
0
0
-
-
-
0
-
-
Financing Cash Flow
-
-
19
0
0
0
9
0
0
Change in Cash
-3
-6
11
-6
-5
-4
6
-3
-3

MetaVia Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-15
-21
-29
-15
-13
-12
-27
-12
Operating Cash Flow
-26
-14
-7
-10
-15
-11
-10
-24
-15
Investing Cash Flow
-
0
-6
0
0
0
0
0
0
Financing Cash Flow
21
17
24
6
22
28
0
18
9
Change in Cash
-5
2
11
-3
6
16
-10
-6
-5

Insights on MetaVia Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MTVA stock has moved up by 22.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 44.2% return, outperforming this stock by 127.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 137.6%

About MetaVia Inc.

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.
OrganisationMetaVia Inc.
Headquarters545 Concord Avenue, Cambridge, MA, United States, 02138
IndustryBiotechnology
CEOMr. Hyung Heon Kim
E-voting on sharesClick here to vote

Key Management of MetaVia Inc.

Name

Title

Mr. Michael C. Pine

Senior Vice President of Business Development Advisor

Mr. Hyung Heon Kim

CEO, President & Director

Mr. Marshall H. Woodworth

Chief Financial Officer

Dr. Mi-Kyung Kim

Chief Scientific Officer

Mr. Robert Homolka

Senior Vice President of Clinical Operations

Dr. W. Christopher Fang M.D.

Consulting Chief Medical Officer & Advisor

FAQs

What is MetaVia Inc. share price today?

MetaVia Inc. share price today is $1.51 as on at the close of the market. MetaVia Inc. share today touched a day high of $1.56 and a low of $1.46.

What is the 52 week high and 52 week low for MetaVia Inc. share?

MetaVia Inc. share touched a 52 week high of $23.1 on and a 52 week low of $1.17 on . MetaVia Inc. stock price today i.e. is closed at $1.51,which is 93.46% down from its 52 week high and 29.06% up from its 52 week low.

What is MetaVia Inc.'s market capitalisation today?

MetaVia Inc. market capitalisation is $0.00T as on .

How to invest in MetaVia Inc. Stock (MTVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MetaVia Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MetaVia Inc. Shares that will get you 0.9934 shares as per MetaVia Inc. share price of $1.51 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy MetaVia Inc. Stock (MTVA) from India?

Indian investors can start investing in MetaVia Inc. (MTVA) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in MetaVia Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on MetaVia Inc. share’s latest price of $1.51 as on April 15, 2026 at 1:29 am IST, you will get 6.6225 shares of MetaVia Inc.. Learn more about fractional shares .